Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT06192251
Recruiting Observational

Complete Lifestyle Medicine Intervention Program

NCT06192251 · tracked via the Priya Life Science Canada tracker
Sponsor
Northern Ontario School of Medicine
Phase
Observational
Started
2023-11-06
Last updated
2024-01-08

Condition(s) studied

High CholesterolDiabetesObesityHypertensionHeart Diseases

Investigational drug(s) / intervention(s)

Lifestyle Medicine

Lifestyle Medicine: Education and support for lifestyle modification to improve health conditions

Study summary

This project will use a mixed design and will be conducted at the West Parry Sound Health Centre. Based on similar studies there is an expected 10% drop-out rate so 20 participants per group will be invited to aim to have 15 finish. Total participants invited over the two-year study will be 40. The participants will be followed over a Complete 6-month Lifestyle medicine Intervention Program (CLIP) involving a collaboration between physicians, health coach, registered dietitians, and kinesiology. The CLIP will cover the 6 pillars of lifestyle medicine in 12-14 fundamentals of lifestyle medicine group classes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * prediabetes, * type 2 diabetes, * pre-hypertension, * systemic hypertension, * heart disease, dyslipidemia, * and/or excess weight (BMI ≥ 25 (42)). Exclusion Criteria: * Healthy participants

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West Parry Sound Health Centre Parry Sound Ontario Recruiting

Other trials for the same condition

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Recruiting
Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Starting soon
Pharmacist Case Finding and Intervention for Vascular Prevention Trial Active, not recruiting
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability Recruiting
Preoperative Optimization of Diabetic Patients Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06192251 on ClinicalTrials.gov ↗ ← All trials in Canada